Literature DB >> 8033917

Growth hormone secretion in children and adolescents with familial tall stature.

M Tauber1, C Pienkowski, P Rochiccioli.   

Abstract

Sixty-five patients (22 boys and 43 girls) presenting with familial tall stature were investigated with regard to growth hormone (GH) secretion, both physiological and after stimulation with thyrotropin releasing hormone (TRH) and growth hormone releasing hormone (GHRH). Plasma insulin-like growth factor-I (IGF-I) was also measured. Two groups of patients were distinguished according to their physiological secretion of GH: a high secretory group (n = 49) with a mean 24 h integrated concentration of GH (IC-GH) of 5.4 +/- 2.3 micrograms/l per minute and a large number of peaks (5.1 +/- 1.6 in 24 h), and a low secretory group (n = 16) with a mean 24 h IC-GH of 2.1 +/- 0.5 micrograms/l per minute and few peaks (3.3 +/- 1.3 in 24 h). Plasma IGF-I levels and GH peak values after the TRH test were significantly higher in the high secretory group. These results indicate that familial tall stature is the consequence either of hypersecretion of GH or of hypersensitivity to this hormone (IGF-I levels being normal in spite of low GH levels).

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8033917     DOI: 10.1007/bf01956408

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  14 in total

1.  Growth hormone receptor and serum binding protein: purification, cloning and expression.

Authors:  D W Leung; S A Spencer; G Cachianes; R G Hammonds; C Collins; W J Henzel; R Barnard; M J Waters; W I Wood
Journal:  Nature       Date:  1987 Dec 10-16       Impact factor: 49.962

Review 2.  A new cytokine receptor superfamily.

Authors:  D Cosman; S D Lyman; R L Idzerda; M P Beckmann; L S Park; R G Goodwin; C J March
Journal:  Trends Biochem Sci       Date:  1990-07       Impact factor: 13.807

3.  Effect of in vitro action of serum proteases or exposure to acid on measurable immunoreactive somatomedin-C in serum.

Authors:  P G Chatelain; J Van Wyk; K C Copeland; S L Blethen; L E Underwood
Journal:  J Clin Endocrinol Metab       Date:  1983-02       Impact factor: 5.958

4.  Growth hormone (GH) response to a single intravenous injection of synthetic GH-releasing hormone in prepubertal children with growth failure.

Authors:  P Chatelain; Y Alamercery; J Blanchard; J P Boissel; D Evain-Brion; M Morre; M Olivier; P Sizonenko; G Van Vliet
Journal:  J Clin Endocrinol Metab       Date:  1987-09       Impact factor: 5.958

5.  Evidence for the specific binding of growth hormone to a receptor-like protein in rabbit serum.

Authors:  S I Ymer; A C Herington
Journal:  Mol Cell Endocrinol       Date:  1985-07       Impact factor: 4.102

6.  Analyses of 24-hour growth hormone profiles in children: relation to growth.

Authors:  K Albertsson-Wikland; S Rosberg
Journal:  J Clin Endocrinol Metab       Date:  1988-09       Impact factor: 5.958

7.  The ontogeny of serum GH binding protein in man: a possible indicator of hepatic GH receptor development.

Authors:  W H Daughaday; B Trivedi; B A Andrews
Journal:  J Clin Endocrinol Metab       Date:  1987-11       Impact factor: 5.958

8.  Association of pharmacological tests and study of 24-hour growth hormone secretion in the investigation of growth retardation in children: analysis of 257 cases.

Authors:  P Rochiccioli; C Pienkowski; M T Tauber; F Uboldi; C Enjaume
Journal:  Horm Res       Date:  1991

9.  Effect of the long-acting somatostatin analogue SMS 201-995 on growth rate and reduction of predicted adult height in ten tall adolescents.

Authors:  M T Tauber; J P Tauber; F Vigoni; A G Harris; P Rochicchioli
Journal:  Acta Paediatr Scand       Date:  1990-02

10.  Growth hormone response to thyrotropin-releasing hormone and oral glucose-loading tests in tall children and adolescents.

Authors:  D Evain-Brion; P Garnier; R M Schimpff; J L Chaussain; J C Job
Journal:  J Clin Endocrinol Metab       Date:  1983-03       Impact factor: 5.958

View more
  1 in total

1.  Growth hormone bioactivity and immunoactivity in tall children.

Authors:  M Bozzola; G Radetti; F Buzi; G Tonini; A Moretta; M Autelli; A Aglialoro; G Rondini; A Barreca
Journal:  J Endocrinol Invest       Date:  1999 Jul-Aug       Impact factor: 4.256

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.